Eléonore Gbary-Lagaud, José Loba, Ramata Kouakou-Kouraogo, Carine Houphouet-Mwandji, Roland Adjoby
{"title":"Ovarian Dysgerminoma Associated With Pregnancy Presenting as Hemoperitoneum: An Obstetric Case Report","authors":"Eléonore Gbary-Lagaud, José Loba, Ramata Kouakou-Kouraogo, Carine Houphouet-Mwandji, Roland Adjoby","doi":"10.1002/ccr3.70203","DOIUrl":null,"url":null,"abstract":"<p>Ovarian dysgerminomas are malignant tumors that are infrequently associated with pregnancy. These tumors are typically detected in cases of abdominal pain or during routine imaging such as ultrasound or magnetic resonance imaging. However, we report a case of ovarian dysgerminoma in an ongoing pregnancy, discovered as a result of hemoperitoneum. A 33-year-old patient at 23 weeks of gestation presented with hemorrhagic shock and hemoperitoneum, requiring emergency surgery. During the operation, a large tumor measuring 24 × 29 cm was found in the left ovary, which was completely invaded by the mass but showed no adhesions to adjacent organs. The condition was accompanied by abundant ascites (4.5 L) mixed with blood, caused by bleeding from an ovarian vessel on the surface of the tumor. Histological examination confirmed the diagnosis of dysgerminoma. Haemoperitoneum is a rare but severe complication that can lead to discovering ovarian dysgerminoma. Owing to the low malignancy of this tumor, adnexectomy is an effective emergency treatment, offering favorable maternal and fetal outcomes in early-stage cases. However, larger case series are required to assess the prognosis of pregnancy associated with dysgerminoma better.</p>","PeriodicalId":10327,"journal":{"name":"Clinical Case Reports","volume":"13 2","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ccr3.70203","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ccr3.70203","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Ovarian dysgerminomas are malignant tumors that are infrequently associated with pregnancy. These tumors are typically detected in cases of abdominal pain or during routine imaging such as ultrasound or magnetic resonance imaging. However, we report a case of ovarian dysgerminoma in an ongoing pregnancy, discovered as a result of hemoperitoneum. A 33-year-old patient at 23 weeks of gestation presented with hemorrhagic shock and hemoperitoneum, requiring emergency surgery. During the operation, a large tumor measuring 24 × 29 cm was found in the left ovary, which was completely invaded by the mass but showed no adhesions to adjacent organs. The condition was accompanied by abundant ascites (4.5 L) mixed with blood, caused by bleeding from an ovarian vessel on the surface of the tumor. Histological examination confirmed the diagnosis of dysgerminoma. Haemoperitoneum is a rare but severe complication that can lead to discovering ovarian dysgerminoma. Owing to the low malignancy of this tumor, adnexectomy is an effective emergency treatment, offering favorable maternal and fetal outcomes in early-stage cases. However, larger case series are required to assess the prognosis of pregnancy associated with dysgerminoma better.
期刊介绍:
Clinical Case Reports is different from other case report journals. Our aim is to directly improve global health and increase clinical understanding using case reports to convey important best practice information. We welcome case reports from all areas of Medicine, Nursing, Dentistry, and Veterinary Science and may include: -Any clinical case or procedure which illustrates an important best practice teaching message -Any clinical case or procedure which illustrates the appropriate use of an important clinical guideline or systematic review. As well as: -The management of novel or very uncommon diseases -A common disease presenting in an uncommon way -An uncommon disease masquerading as something more common -Cases which expand understanding of disease pathogenesis -Cases where the teaching point is based on an error -Cases which allow us to re-think established medical lore -Unreported adverse effects of interventions (drug, procedural, or other).